Cardlytics' Asset Writedowns and Impairment fell 5528.48% to $58.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.7 million, marking a year-over-year decrease of 7036.16%. This contributed to the annual value of $131.6 million for FY2024, which is 8661.19% up from last year.
As of Q3 2025, Cardlytics' Asset Writedowns and Impairment stood at $58.8 million, which was down 5528.48% from $1.2 million recorded in Q2 2025.
Over the past 5 years, Cardlytics' Asset Writedowns and Impairment peaked at $452.3 million during Q4 2022, and registered a low of -$246000.0 during Q1 2023.
For the 5-year period, Cardlytics' Asset Writedowns and Impairment averaged around $40.1 million, with its median value being $842500.0 (2022).
As far as peak fluctuations go, Cardlytics' Asset Writedowns and Impairment surged by 17254847.33% in 2022, and later plummeted by 17109.83% in 2023.
Quarter analysis of 5 years shows Cardlytics' Asset Writedowns and Impairment stood at $262000.0 in 2021, then surged by 172548.47% to $452.3 million in 2022, then plummeted by 84.67% to $69.4 million in 2023, then soared by 89.71% to $131.6 million in 2024, then plummeted by 55.28% to $58.8 million in 2025.
Its Asset Writedowns and Impairment was $58.8 million in Q3 2025, compared to $1.2 million in Q2 2025 and $643000.0 in Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value